NLS Pharmaceutics AG

NASDAQ (USD): NLS Pharmaceutics AG (NLSP)

Last Price

4.30

Today's Change

+0.01 (0.23%)

Day's Change

4.30 - 4.30

Trading Volume

1,109

Overview

Market Cap

10 Million

Shares Outstanding

2 Million

Avg Volume

70,290

Avg Price (50 Days)

5.55

Avg Price (200 Days)

8.91

PE Ratio

-0.64

EPS

-6.74

Earnings Announcement

26-Feb-2025

Previous Close

4.29

Open

4.30

Day's Range

4.3 - 4.3

Year Range

4.08 - 29.68

Trading Volume

1,109

Price Change Highlight

1 Day Change

0.24%

5 Day Change

-14.00%

1 Month Change

-18.71%

3 Month Change

-45.22%

6 Month Change

-18.87%

Ytd Change

-81.72%

1 Year Change

-79.33%

3 Year Change

-95.24%

5 Year Change

-96.28%

10 Year Change

-96.28%

Max Change

-96.28%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment